Pterostilbene vs Resveratrol: What Does the Science Say About These Plant-Based Compounds?

Both pterostilbene and resveratrol are stilbene polyphenols with similar base structures. The key structural difference is that pterostilbene carries two methoxy groups at the 3 and 5 positions, where resveratrol instead has hydroxyl groups at those positions. 

This structural difference may influence how pterostilbene is absorbed and distributed in the body, based on recent pharmacokinetic research conducted primarily in preclinical models. 

While preclinical pharmacokinetic data from animal models suggest pterostilbene may be more readily taken up by the body, resveratrol's substantially larger body of human clinical research makes it the more thoroughly studied option for daily wellness support. That distinction in research depth is worth considering when evaluating either compound as a supplement ingredient.

Bioavailability is one of the most discussed points when comparing these two polyphenols in supplement research, and the picture is not as straightforward as it may seem.

• Pterostilbene may absorb more readily, though this is largely based on preclinical data. Pharmacokinetic research in animal models suggests pterostilbene may have higher oral bioavailability than resveratrol. For example, one rat study found pterostilbene to be approximately 80% bioavailable compared to approximately 20% for resveratrol at equivalent oral doses. Direct human head-to-head comparisons are not yet well established. 

• Resveratrol appears to be rapidly converted in the body. Once ingested, it is thought to be quickly transformed into conjugated forms, which research suggests may affect how much free resveratrol reaches the bloodstream.

• Some human studies have noted associations between resveratrol intake and wellness outcomes. A 2018 systematic review of human resveratrol intervention trials examined resveratrol's effects on specific markers — including inflammatory markers, metabolic indicators, and cardiovascular measures — in participants with various health conditions. Results varied across trials, and the review did not establish definitive conclusions applicable to the general population. 

• Doses around 150mg/day have been used across multiple resveratrol clinical trials. A 2024 systematic review of resveratrol clinical trials identified 194 studies involving over 6,000 participants and a range of doses. While this does not confirm the same outcomes in all individuals, 150 mg falls within the dose ranges used in published human trials. 

• Certain formulation approaches may support resveratrol absorption. A 2018 review of human resveratrol trials noted that formulation factors such as particle size and the food matrix may influence how resveratrol is absorbed. The review found that micronized resveratrol produced higher peak plasma concentrations in studied participants than non-micronized forms at the same dose. 

• When weighing bioavailability against research depth, resveratrol may be the more thoroughly studied option in human populations. Preclinical pharmacokinetic comparisons referenced in a human safety trial on pterostilbene were drawn primarily from animal models, which do not always translate directly to human outcomes.

When it comes to which plant-based polyphenol has more published research for wellness support, resveratrol has a substantially larger body of human clinical evidence. That difference in research volume matters for those who want a supplement grounded in human study data.

A 2024 systematic review of resveratrol clinical trials identified 194 studies — including 104 randomized controlled trials — involving a total of more than 6,000 participants across a range of health conditions. 

Resveratrol has been examined across a range of wellness-related outcomes, from antioxidant activity to metabolic markers. That volume of human data may offer a meaningful reference point for those exploring polyphenol supplementation.

Most pterostilbene studies to date have focused on safety rather than efficacy outcomes. One of the most notable published human safety trials was a randomized, double-blind, placebo-controlled study enrolling 80 adults with hypercholesterolemia over 6–8 weeks. 

The study found no significant adverse drug reactions and concluded that pterostilbene was generally safe at doses up to 250 mg/day in this population. 

Pterostilbene has accumulated fewer human trials than resveratrol has, and its research base is still developing.

Resveratrol is one of the more extensively studied polyphenols in human research, and Akka's formulation reflects a focus on ingredients with a documented human trial record. 

When two compounds share similar origins and overlapping research, it's natural to wonder which one belongs in your daily routine. Both compounds have real science behind them, and the distinctions between them are worth knowing before you choose.

When comparing plant-based polyphenols, it's important to look beyond bioavailability alone. The strength of the human research behind an ingredient is equally important. Akka by Enclave BioActives includes resveratrol because it has been studied more extensively in human clinical research, alongside complementary botanicals selected to support liver wellness, the gut-liver axis, and antioxidant balance as part of a science-informed daily routine.

• Three-Step Framework: Supports healthy microbial balance with berberine; supports gut barrier function with quercetin and DGL (deglycyrrhizinated licorice root extract); and restores natural motility with chicory root inulin and star anise extract.

• Clinically Informed Dosing: Each bioactive is selected and dosed with reference to available peer-reviewed research.

• Nature-Derived Ingredients: Botanical compounds that work synergistically to work synergistically with your microbiome's natural diversity.

• Developed With Scientific Guidance: Every product is formulated with input from our medical advisory board. 

Every purchase comes with a 90-day money-back guarantee and free shipping on subscriptions because we believe in what we create.

This article is educational only and should not be used for self-diagnosis. If you experience any symptoms described here, consult your healthcare provider for proper medical evaluation and treatment. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary.